— Know what they know.
Not Investment Advice

KA NASDAQ

Kineta, Inc.
1W: +0.7% 1M: -19.7% 3M: -15.5% 1Y: -83.1% 3Y: -96.1% 5Y: -97.6%
$0.57
Last traded 2024-10-14 — delisted
NASDAQ · Healthcare · Biotechnology · $7.0M mcap · 8M float · 6.37% daily turnover

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
$0 -100.0% ▼
Operating Income
-$14M +13.9% ▲
Net Income
-$17M -21.5% ▼
EPS (Diluted)
$-1.42 -10.9% ▼
EBITDA
-$14M +13.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$10M$9M$2M$5M$0
YoY Growth+109.8%-13.3%-78.5%+178.6%-100.0%
Cost of Revenue$0$669K$734K$9K$0
Gross Profit$10M$8M$1M$5M$0
Gross Margin100.0%92.6%62.4%99.8%—
R&D Expenses$9M$16M$35M$9M$5M
SG&A Expenses$4M$5M$9M$12M$8M
Operating Expenses$14M$20M$43M$21M$14M
Operating Income-$3M-$11M-$42M-$16M-$14M
Operating Margin-29.7%-122.0%-2126.5%-288.9%—
Interest Expense$5M$1M$4M$337K$138K
Income Before Tax-$7M-$12M-$63M-$14M-$17M
Tax Expense$0$0$0$0$0
Net Income-$14M-$12M-$63M-$14M-$17M
Net Margin-132.3%-131.6%-3229.2%-259.1%—
EPS (Diluted)$-41.26$-8.14$-12.80$-1.28$-1.42
EBITDA-$3M-$10M-$42M-$14M-$14M
Shares Outstanding3363061M5M11M12M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms